About Akesis

At Akesis…

We believe people suffering from cancer and other intracranial diseases deserve the benefits of precise SRS treatment.

We believe clinicians should have the advanced tools they need to save lives and spare healthy tissue.

We believe healthcare providers should have affordable technology options that provide long-term value.

We’re Akesis. And we’re simplifying SRS.

January

Private investors recognize the global opportunity.

March

Veteran team of radiation oncology experts tapped to form new company.

November

Akesis, Inc. is established. Akesis is a Greek god of healing.

August

Grand Opening for new headquarters and manufacturing center.

October

Akesis exhibits at ASTRO 2018.

January

Contracts and supplier partnerships established.

August

Manufacturing begins on our first products.

September 4th

FDA clearance received for Akesis Galaxy.

September 11-13th

Akesis exhibits at the ALATRO congress in Santiago, Chile.

September 15-18th

Akesis exhibits at the ASTRO Annual Meeting in Chicago.

October

Akesis exhibits at South African Association of Physicists in Medicine and Biology congress in Cape Town, South Africa.

October

Akesis Receives California Food and Drug Branch (FDB) Device Manufacturing License.

December

Akesis exhibits at the ASTRO meets Asia congress in Singapore.

January 27-29th

Akesis exhibits at Arab Health 2020 in Dubai.

February

Akesis Galaxy RTx receives FDA 510(k) clearance.

March

Akesis Galaxy RTi receives FDA 510(k) clearance.